{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+DC", "query": { "intervention": "Placebo DC" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 27, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+DC&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T05:16:20.648Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02301611", "title": "Phase IIB TL + YCWP + DC in Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "TLPLDC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elios Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 187, "start_date": "2015-01", "completion_date": "2022-05-11", "has_results": true, "last_update_posted_date": "2024-11-29", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02301611" }, { "nct_id": "NCT06533280", "title": "VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Part A, C and D: VH3739937 500 mg", "type": "DRUG" }, { "name": "Part A: VH3739937 100 mg", "type": "DRUG" }, { "name": "Part A and C: Placebo", "type": "DRUG" }, { "name": "Part B: Treatment A", "type": "DRUG" }, { "name": "Part B: Treatment B", "type": "DRUG" }, { "name": "Part B: Treatment C", "type": "DRUG" }, { "name": "Part B: Treatment D", "type": "DRUG" }, { "name": "Part B: Treatment E", "type": "DRUG" }, { "name": "Part D: Probe cocktail", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 0, "start_date": "2024-08-02", "completion_date": "2024-08-14", "has_results": false, "last_update_posted_date": "2025-04-22", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06533280" }, { "nct_id": "NCT01204684", "title": "Dendritic Cell Vaccine for Patients With Brain Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioma", "Anaplastic Astrocytoma", "Anaplastic Astro-oligodendroglioma", "Glioblastoma" ], "interventions": [ { "name": "autologous tumor lysate-pulsed DC vaccination", "type": "BIOLOGICAL" }, { "name": "Tumor lysate-pulsed DC vaccination+0.2% resiquimod", "type": "BIOLOGICAL" }, { "name": "Tumor-lysate pulsed DC vaccination +adjuvant polyICLC", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 24, "start_date": "2010-10-08", "completion_date": "2024-08-21", "has_results": false, "last_update_posted_date": "2024-08-28", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01204684" }, { "nct_id": "NCT05457959", "title": "Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diffuse Hemispheric Glioma, H3 G34-Mutant" ], "interventions": [ { "name": "Dendritic Cell Tumor Peptide Vaccine", "type": "BIOLOGICAL" }, { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Poly ICLC", "type": "DRUG" }, { "name": "Resection", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "13 Years to 60 Years" }, "enrollment_count": 0, "start_date": "2024-12-01", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2025-02-24", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05457959" }, { "nct_id": "NCT07507370", "title": "CARED : A Novel Rapid Treatment Paradigm for Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Intermittent Theta Burst Stimulation (iTBS)", "type": "DEVICE" }, { "name": "Transcranial Alternating Current Stimulation (tACS)", "type": "DEVICE" }, { "name": "Psychotherapy", "type": "BEHAVIORAL" }, { "name": "Sham (Placebo) Transcranial Alternating Current Stimulation (tACS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2026-04-14", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07507370" }, { "nct_id": "NCT01173601", "title": "A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "LY2216684", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "SSRI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1416, "start_date": "2010-11", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2018-04-17", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 22, "location_summary": "Irvine, California • La Habra, California • Redlands, California + 19 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "La Habra", "state": "California" }, { "city": "Redlands", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01173601" }, { "nct_id": "NCT06807437", "title": "Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pancreatic Carcinoma", "Pancreatic Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Distal Pancreatectomy", "type": "PROCEDURE" }, { "name": "Lanreotide", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 274, "start_date": "2025-05-09", "completion_date": "2027-11-01", "has_results": false, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 118, "location_summary": "Birmingham, Alabama • Daphne, Alabama • Fairhope, Alabama + 93 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Saraland", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06807437" }, { "nct_id": "NCT00521196", "title": "Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "DC Stimulator (Transcranial Direct Current Stimulator)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2007-07", "completion_date": "2012-01-13", "has_results": false, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521196" }, { "nct_id": "NCT01511614", "title": "Nicotine Withdrawal Symptoms and Smoking Relapse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nicotine Dependence" ], "interventions": [ { "name": "Transcranial Direct Current Stimulation", "type": "DEVICE" }, { "name": "sham", "type": "DEVICE" }, { "name": "Nicotine patch", "type": "DRUG" }, { "name": "Placebo patch", "type": "DRUG" }, { "name": "Varenicline Pill", "type": "DRUG" }, { "name": "Placebo pill", "type": "DRUG" }, { "name": "Motivational Interviewing", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "DRUG", "BEHAVIORAL" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 112, "start_date": "2013-05-20", "completion_date": "2020-03-30", "has_results": true, "last_update_posted_date": "2024-05-31", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01511614" }, { "nct_id": "NCT02067689", "title": "Cognitive Stimulation Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Transcranial Direct Current Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 18, "start_date": "2016-01", "completion_date": "2019-05-10", "has_results": false, "last_update_posted_date": "2020-01-28", "last_synced_at": "2026-09-07T05:16:20.648Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02067689" } ] }